Daily Management Review

Israel The First Country To Will Offer Fourth Dose Of Covid-19 Vaccine For Over-60 Citizens


Israel The First Country To Will Offer Fourth Dose Of Covid-19 Vaccine For Over-60 Citizens
Israel said on Tuesday that it will offer a fourth dose of Covid-19 vaccine to older people, amid growing concerns about the spread Omicron variant of the coronavirus.
The fourth shot was recommended by a panel of experts from the Health Ministry of the country. Prime Minister Naftali Bennett quickly welcomed the decision as "great news" that would help the country to overcome the Omicron wave that is spreading across the globe.
Bennett said that while the official approval of senior health officials is still pending, He urged Israelis not to delay in getting the vaccine.
This decision comes after the first Omicron variant-positive patient died in Israel. A hospital in Israel confirmed his death on Tuesday, but stated that he had been suffering from serious pre-existing conditions.
Beersheba's Soroka Medical Center reported that the man, who was in his 60s, had died on Monday. This happened two weeks after he was admitted for coronavirus.
According to a hospital statement, the patient had a number of serious illnesses.
"His morbidity stemmed mainly from pre-existing sicknesses and not from respiratory infection arising from the coronavirus,” it said.
The Health Ministry of Israel reported on Tuesday that there are at least 340 Omicron cases in Israel.
To stop the spread of the virus, Israel has extended a travel ban to Canada, the United States, Italy, Turkey, and Germany this week.
Bennett's office stated that it also approved reducing the attendance of public sector employees by 50 per cent to encourage remote work.
His office stated that Benny Gantz, Defence Minister, ordered the Homefront Command to be ready for the possibility of 5,000 new cases per hour.
The company stated that the third dose of Novavax, NVXCoV2373, was recommended by the WHO panel of experts.
SAGE is the WHO's Strategic Advisory Group of Experts on Immunization. It issued a number of recommendations including that the vaccine be used in people with comorbidities, women who are breastfeeding, and HIV-positive persons.
Independent experts reviewed Novavax data and concluded that the vaccine could be administered to pregnant women if there are no risks.
The WHO issued an emergency use list to Novavax's vaccine, made by Serum Institute of India. This is a major vaccine manufacturer in the world and will allow it to be used in low- and medium-income countries, where its rollout has been slower than in Europe. Continue reading
Novavax announced Monday that it has been granted the WHO emergency use listing to distribute its own vaccine in Europe. Continue reading
On Tuesday, the company announced that it had started administering booster doses of NVXCoV2373 to patients in a late-stage clinical trial.